---
title: "LaiMei Pharmaceutical: Guangtou Group plans to increase capital and expand shares in Guangtou JinKong with 25.94% of Zhongheng Group shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/242554241.md"
description: "LaiMei Pharmaceutical announced that its indirect controlling shareholder GuangTou Group plans to increase the capital of its subsidiary GuangTou JinKong by using the 859 million shares of Zhongheng Group it holds. This transaction falls under the category of state-owned equity changes under the same control. After the transaction is completed, GuangTou JinKong will become the indirect controlling shareholder of the company, while Zhongheng Group will remain the direct controlling shareholder, and the Guangxi State-owned Assets Supervision and Administration Commission will still be the actual controller of the company. The aforementioned equity change is still in the planning stage and needs to go through state-owned asset approval procedures and related legal procedures"
datetime: "2025-05-30T09:59:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/242554241.md)
  - [en](https://longbridge.com/en/news/242554241.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/242554241.md)
---

# LaiMei Pharmaceutical: Guangtou Group plans to increase capital and expand shares in Guangtou JinKong with 25.94% of Zhongheng Group shares

LaiMei Pharmaceutical announced that its indirect controlling shareholder GuangTou Group intends to increase the capital of GuangTou JinKong, a holding subsidiary of GuangTou Group, by using its 859 million shares of Zhongheng Group. This transaction falls under the change of state-owned equity under the same control. After the transaction is completed, GuangTou JinKong will become the indirect controlling shareholder of the company, while Zhongheng Group will remain the direct controlling shareholder, and the Guangxi State-owned Assets Supervision and Administration Commission will still be the actual controller of the company. The above-mentioned equity change is still in the planning stage and needs to go through the state-owned assets approval process and related legal procedures

### Related Stocks

- [600252.CN](https://longbridge.com/en/quote/600252.CN.md)
- [300006.CN](https://longbridge.com/en/quote/300006.CN.md)

## Related News & Research

- [Exploring Three Undiscovered Gems in the Middle East Market](https://longbridge.com/en/news/286881831.md)
- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [China Telecom's Shares Rise After Becoming Last of Country's Big Three Telcos to Roll Out Token Plans](https://longbridge.com/en/news/286859736.md)
- [15:37 ETMuse Communications Celebrates 10 Years of Award-Winning Legal Marketing and Public Relations](https://longbridge.com/en/news/286811115.md)
- [Hamlet BioPharma announces investor meeting alongside Q3 report release](https://longbridge.com/en/news/287189797.md)